These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2859842)
1. Gastric secretion and hormonal interactions in multiple endocrine neoplasia type I. Gogel HK; Buckman MT; Cadieux D; McCarthy DM Arch Intern Med; 1985 May; 145(5):855-9. PubMed ID: 2859842 [TBL] [Abstract][Full Text] [Related]
2. Lack of effect of parathyroidectomy or calcium channel blockade on serum gastrin concentration and gastric acid secretion in a patient with hyperparathyroidism and Zollinger-Ellison syndrome. Stevens MH; Thirlby RC; Richardson CT Surgery; 1987 Jan; 101(1):108-13. PubMed ID: 3798319 [TBL] [Abstract][Full Text] [Related]
3. Serum gastrin and its response to secretin in hyperparathyroid patients. Selking O; Johansson H; Lundqvist G Acta Chir Scand; 1981; 147(8):649-55. PubMed ID: 7344385 [TBL] [Abstract][Full Text] [Related]
4. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. Norton JA; Cornelius MJ; Doppman JL; Maton PN; Gardner JD; Jensen RT Surgery; 1987 Dec; 102(6):958-66. PubMed ID: 2891201 [TBL] [Abstract][Full Text] [Related]
5. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas. Ellison EC; O'Dorisio TM; Sparks J; Mekhjian HS; Fromkes JJ; Woltering EA; Carey LC Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819 [TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia, type I (MEN I). Eberle F; GrĂ¼n R Ergeb Inn Med Kinderheilkd; 1981; 46():76-149. PubMed ID: 6262073 [No Abstract] [Full Text] [Related]
7. Serum gastrin level is increased by chronic hypercalcemia of parathyroid or nonparathyroid origin. Zaniewski M; Jordan PH; Yip B; Thornby JI; Mallette LE Arch Intern Med; 1986 Mar; 146(3):478-82. PubMed ID: 2869739 [TBL] [Abstract][Full Text] [Related]
8. Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1--report of a further family and a review of th literature. Betts JB; O'Malley BP; Rosenthal FD Q J Med; 1980; 49(193):69-76. PubMed ID: 6107954 [TBL] [Abstract][Full Text] [Related]
9. [Multiple endocrine neoplasms associated with Zollinger-Ellison syndrome and hyperparathyroidism]. Tellaroli JC; Charleux H; Semin AM; Parrot B; Fasano JJ; Cain P Ann Gastroenterol Hepatol (Paris); 1984; 20(4):199-201. PubMed ID: 6152141 [TBL] [Abstract][Full Text] [Related]
10. Does hyperparathyroidism cause hypergastrinemia? Wilson SD; Singh RB; Kalkhoff RK Surgery; 1976 Aug; 80(2):231-7. PubMed ID: 941095 [TBL] [Abstract][Full Text] [Related]
11. Zollinger-Ellison syndrome associated with parathyroid adenomas and ectopic gastric tissue in the lower esophageal mucosa. Nakayasu A; Dowell AJ; Reynolds C; Stordy SN; Cleator IG Can J Surg; 1979 Jan; 22(1):71-8. PubMed ID: 445242 [TBL] [Abstract][Full Text] [Related]
12. [Biological diagnosis of Zollinger-Ellison syndrome in the context of a polyendocrine adenomatosis]. Bonfils S; Bernades P; Letonturier P Nouv Presse Med; 1975 Aug 30-Sep 6; 4(28):2027-31. PubMed ID: 241055 [TBL] [Abstract][Full Text] [Related]
13. Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome. Isenberg JI; Walsh JH; Passaro E; Moore EW; Grossman MI Gastroenterology; 1972 Apr; 62(4):626-31. PubMed ID: 5020875 [No Abstract] [Full Text] [Related]
14. [Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999]. Mignon M Bull Acad Natl Med; 2003; 187(7):1249-58; discussion 1259-60. PubMed ID: 15146602 [TBL] [Abstract][Full Text] [Related]
15. A case of Zollinger-Ellison syndrome produced by gastrinoma in the duodenum accompanied with multiple endocrine neoplasia type 1. Yazawa K; Kuroda T; Watanabe H; Shimozawa N; Nakata S; Fujimori Y; Koide N; Koike S; Kajikawa S; Adachi W; Amano J Hepatogastroenterology; 1999; 46(25):257-60. PubMed ID: 10228803 [TBL] [Abstract][Full Text] [Related]
16. Multiple endocrine neoplasia type 1--presenting with impotence. Lye WC; Lee KO; Tay HH Singapore Med J; 1990 Jun; 31(3):277-9. PubMed ID: 1975461 [TBL] [Abstract][Full Text] [Related]
17. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma. Wada M; Komoto I; Doi R; Imamura M World J Surg; 2002 Oct; 26(10):1291-6. PubMed ID: 12205549 [TBL] [Abstract][Full Text] [Related]
18. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936 [TBL] [Abstract][Full Text] [Related]
19. Zollinger-Ellison syndrome in 2006: concepts from a clinical point of view. Pellicano R; De Angelis C; Resegotti A; Rizzetto M Panminerva Med; 2006 Mar; 48(1):33-40. PubMed ID: 16633330 [TBL] [Abstract][Full Text] [Related]